XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (2,698,371) $ (797,309)
Net loss from discontinued operation (256,007)
Net loss from continuing operations (2,698,371) (541,302)
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation 45,208 396
Amortization 11,768 1,248
Provision (recovery) of doubtful debts 2,002 (15,224)
Share-based payments 893,250 893,250
Impairment of short term investment 248,512
Interest expenses related to convertible note (96,691)
Changes in operating assets and liabilities    
Accounts receivable 1,284,130
Inventory
Other receivable (437,335) (165,207)
Advances to suppliers and other current assets 563,832 12,277
Accrued expenses (404,870) (653,418)
Proceeds from amounts due from related parties, net 165,492 94,846
Repayment of amounts due to related parties, net (312,270) (968,855)
Advances from customers 13 (273)
Net Cash Used in Operating Activities – Discontinued Operations (638,639) (1,438,953)
Net Cash Used in Operating Activities – Continued Operations (1) (223,891)
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to property, plant and equipment (17,902)
Payment for loan receivable (5,000,000)
Repayment for loan receivable 6,000,000
Purchase of intangible assets (570,351)
Net Cash Provided by Investing Activities from Continued Operations 411,747
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of common stock, net of issuance costs 35,496,846
Proceeds from loan payable 3,621,827
Repayment of convertible payable (1,163,146)
Payment of dividends to the non-controlling interest (63,477)
Net cash provided by financing activities 3,558,350 34,333,700
Effect of change in exchange rate 32,969 21,955
NET INCREASE IN CASH AND CASH EQUIVALENTS 3,364,426 32,692,811
Cash and cash equivalents, beginning of period 50,273,517 9,425,312
Cash and cash equivalents, end of period 53,637,943 42,118,123
Less: Cash and cash equivalents from the discontinued operations, end of period (186,420)
Cash and cash equivalents, from the continuing operations end of period 53,637,943 41,931,703
SUPPLEMENTARY DISCLOSURE OF SIGNIFICANT NON-CASH TRANSACTION    
Issuance of common stocks for conversion of debts